HCW Biologics Inc. (HCWB)
Nasdaq: HCWB · Pharmaceutical Preparations · Miramar, FL · filing with the SEC since 2020
Who runs HCW Biologics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Wong Hing C
Chief Executive Officer. First filing Jul 2021, latest Jul 31, 2026, 16 filings in all.
Officers reporting now
3
of 4 people with a filing in the last fifteen months
Directors reporting now
1
9 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Wong Hing C | Chief Executive Officer | Jul 2021 | Jul 31, 2026 | none |
| Flowers Lee | SVP of Business Development | Jul 2021 | Jul 31, 2026 | none |
| Byam Rebecca | Chief Financial Officer | Jul 2021 | May 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Garrett Scott T | director | Jul 2021 | Jul 31, 2026 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.